INVA vs. OCUL
Compare and contrast key facts about Innoviva, Inc. (INVA) and Ocular Therapeutix, Inc. (OCUL).
Performance
INVA vs. OCUL - Performance Comparison
Loading graphics...
INVA vs. OCUL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
INVA Innoviva, Inc. | 16.56% | 15.22% | 8.17% | 21.06% | -23.19% | 39.23% | -12.50% | -18.85% | 22.97% | 32.62% |
OCUL Ocular Therapeutix, Inc. | -30.23% | 42.15% | 91.48% | 58.72% | -59.68% | -66.33% | 424.05% | -0.75% | -10.56% | -46.83% |
Fundamentals
INVA:
$1.99B
OCUL:
$1.89B
INVA:
$3.19
OCUL:
-$1.38
INVA:
4.81
OCUL:
31.49
INVA:
1.69
OCUL:
2.89
INVA:
$411.33M
OCUL:
$51.95M
INVA:
$307.67M
OCUL:
$45.25M
INVA:
$203.88M
OCUL:
-$258.96M
Returns By Period
In the year-to-date period, INVA achieves a 16.56% return, which is significantly higher than OCUL's -30.23% return. Over the past 10 years, INVA has outperformed OCUL with an annualized return of 6.15%, while OCUL has yielded a comparatively lower -1.51% annualized return.
INVA
- 1D
- 1.70%
- 1M
- 1.48%
- YTD
- 16.56%
- 6M
- 27.67%
- 1Y
- 28.52%
- 3Y*
- 27.47%
- 5Y*
- 14.27%
- 10Y*
- 6.15%
OCUL
- 1D
- 14.46%
- 1M
- -5.26%
- YTD
- -30.23%
- 6M
- -27.54%
- 1Y
- 15.55%
- 3Y*
- 17.14%
- 5Y*
- -13.42%
- 10Y*
- -1.51%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INVA vs. OCUL — Risk / Return Rank
INVA
OCUL
INVA vs. OCUL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Innoviva, Inc. (INVA) and Ocular Therapeutix, Inc. (OCUL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| INVA | OCUL | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.02 | 0.21 | +0.81 |
Sortino ratioReturn per unit of downside risk | 1.86 | 0.91 | +0.95 |
Omega ratioGain probability vs. loss probability | 1.21 | 1.11 | +0.10 |
Calmar ratioReturn relative to maximum drawdown | 1.20 | 0.20 | +0.99 |
Martin ratioReturn relative to average drawdown | 2.86 | 0.52 | +2.34 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| INVA | OCUL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.02 | 0.21 | +0.81 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.51 | -0.17 | +0.69 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.18 | -0.02 | +0.20 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.06 | -0.05 | +0.10 |
Correlation
The correlation between INVA and OCUL is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
INVA vs. OCUL - Dividend Comparison
Neither INVA nor OCUL has paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
INVA Innoviva, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 7.12% |
OCUL Ocular Therapeutix, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
INVA vs. OCUL - Drawdown Comparison
The maximum INVA drawdown since its inception was -84.32%, smaller than the maximum OCUL drawdown of -95.19%. Use the drawdown chart below to compare losses from any high point for INVA and OCUL.
Loading graphics...
Drawdown Indicators
| INVA | OCUL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.32% | -95.19% | +10.87% |
Max Drawdown (1Y)Largest decline over 1 year | -23.53% | -57.29% | +33.76% |
Max Drawdown (5Y)Largest decline over 5 years | -47.01% | -89.14% | +42.13% |
Max Drawdown (10Y)Largest decline over 10 years | -59.57% | -90.94% | +31.37% |
Current DrawdownCurrent decline from peak | -27.14% | -80.43% | +53.29% |
Average DrawdownAverage peak-to-trough decline | -44.79% | -76.58% | +31.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.85% | 22.71% | -12.86% |
Volatility
INVA vs. OCUL - Volatility Comparison
The current volatility for Innoviva, Inc. (INVA) is 6.54%, while Ocular Therapeutix, Inc. (OCUL) has a volatility of 19.52%. This indicates that INVA experiences smaller price fluctuations and is considered to be less risky than OCUL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| INVA | OCUL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.54% | 19.52% | -12.98% |
Volatility (6M)Calculated over the trailing 6-month period | 22.06% | 58.02% | -35.96% |
Volatility (1Y)Calculated over the trailing 1-year period | 28.15% | 75.47% | -47.32% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.88% | 78.73% | -50.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.05% | 80.20% | -46.15% |
Financials
INVA vs. OCUL - Financials Comparison
This section allows you to compare key financial metrics between Innoviva, Inc. and Ocular Therapeutix, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities